Edesa Biotech Inc 2023年度报告

FORM 10-K ☐ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period fromto Commission file number: 001-37619 100 Spy Court, Markham, ON, Canada L3R 5H6(289) 800-9600(Address of principal executive offices and zip code)(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on whichregisteredThe Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the SecuritiesAct. Yes☐No☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) ofthe Act. Yes☐No☐ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that theregistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90days. Yes☐No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required tobe submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months(or for such shorter period that the registrant was required to submit such files). Yes☐No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-acceleratedfiler, a smaller reporting company, or an emerging growth company. See the definitions of “large acceleratedfiler,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of theExchange Act. Large accelerated filer☐Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant toSection 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’sassessment of the effectiveness of its internal control over financial reporting under Section 404(b) of theSarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its auditreport.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financialstatements of the registrant included in the filing reflect the correction of an error to previously issuedstatements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysisof incentive-based compensation received by any of the registrant’s executive officers during the relevantrecovery period pursuant to Section 240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes☐No☐ As of March 31, 2024, the last business day of the registrant’s most recently completed second fiscal quarter, theaggregate market value of the registrant’s outstanding common shares held by nonaffiliates was approximately$11,056,198, which was calculated based on 3,215,968 common shares outstanding as of that date, of which2,664,144 common shares were held by nonaffiliates at the closing price of the registrant’s common shares onThe Nasdaq Capital Market on such date. As of December 11, 2024, the registrant had 3,467,658 common shares issued and outstanding. DOCUMENTS INCORPORATED BY REFERENCE: NONE Table of Contents Page ItemPART I1.Business41A.Risk Factors221B.Unresolved Staff Comments41 1C.Cybersecurity412.Properties423.Legal Proceedings424.Mine Safety Disclosures42 PART II 5.Market for Registrant’s Common Equity, Related Stockholder Matters and IssuerPurchases of Equity Securities436.[Reserved]437.Management’s Discussion and Analysis of Financial Condition and Results of Operations437A.Quantitative and Qualitative Disclosures about Market Risk498.Financial Statements and Supplementary Data499.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure499A.Controls and Procedures499B.Other Information509C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections50 PART III 10.Directors, Executive Officers and Corporate Governance5111.Executive Compensation5412.Security Ownership of Certain Beneficial Owners and Management and RelatedStockholder Matters6313.Certain Relationships and Related Transactions, and Director Independence6514.Principal Accounting Fees and Services66 PART IV FORWARD-LOOKING STATEMENTS AND OTHER MATTERS This Annual Report on Form 10-K contains